Literature DB >> 16981711

Detergent-mediated phospholipidation of plasma lipoproteins increases HDL cholesterophilicity and cholesterol efflux via SR-BI.

Henry J Pownall1.   

Abstract

Cellular cholesterol efflux is an early, obligatory step in reverse cholesterol transport, the putative antiatherogenic mechanism by which human plasma high-density lipoproteins (HDL) transport cholesterol from peripheral tissue to the liver for recycling or disposal. HDL-phospholipid content is the essential cholesterol-binding component of lipoproteins and therefore a major determinant of cholesterol efflux. Thus, increased phospholipidation of lipoproteins, particularly HDL, is one strategy for increasing cholesterol efflux. This study validates a simple, new detergent perturbation method for the phospholipidation of plasma lipoproteins; we have quantified the cholesterophilicity of human plasma lipoproteins and the effects of lipoprotein phospholipidation on cholesterophilicity and cellular cholesterol efflux mediated by the class B type I scavenger receptor (SR-BI). We determined that low-density lipoproteins (LDL) are more cholesterophilic than HDL and that LDL has a higher affinity for phospholipids than HDL whereas HDL has a higher phospholipid capacity than LDL. Phospholipidation of total human plasma lipoproteins enhances cholesterol efflux, an effect that occurs largely through the preferential phospholipidation of HDL. We conclude that increasing HDL phospholipid increases its cholesterophilicity, thereby making it a better acceptor of cellular cholesterol efflux. Phospholipidation of lipoproteins by detergent perturbation is a simple way to increase HDL cholesterophilicity and cholesterol efflux in a way that may be clinically useful.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981711      PMCID: PMC2556864          DOI: 10.1021/bi0608717

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Alterations in serum phosphatidylcholine fatty acyl species by eicosapentaenoic and docosahexaenoic ethyl esters in patients with severe hypertriglyceridemia.

Authors:  B J McKeone; K Osmundsen; D Brauchi; Q Pao; C Payton-Ross; C Kilinç; F A Kummerow; H J Pownall
Journal:  J Lipid Res       Date:  1997-03       Impact factor: 5.922

3.  Sequential flotation ultracentrifugation.

Authors:  V N Schumaker; D L Puppione
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  Human plasma lecithin-cholesterol acyltransferase. Characterization of cofactor-dependent phospholipase activity.

Authors:  L Aron; S Jones; C J Fielding
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

5.  Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins.

Authors:  J B Massey; D Hickson; H S She; J T Sparrow; D P Via; A M Gotto; H J Pownall
Journal:  Biochim Biophys Acta       Date:  1984-07-06

6.  Action of lecithin:cholesterol acyltransferase on model lipoproteins. Preparation and characterization of model nascent high density lipoprotein.

Authors:  H J Pownall; W B Van Winkle; Q Pao; M Rohde; A M Gotto
Journal:  Biochim Biophys Acta       Date:  1982-12-13

7.  Kinetics and mechanism of free cholesterol exchange between human serum high- and low-density lipoproteins.

Authors:  S Lund-Katz; B Hammerschlag; M C Phillips
Journal:  Biochemistry       Date:  1982-06-08       Impact factor: 3.162

8.  Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions.

Authors:  C E Matz; A Jonas
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

9.  The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

Authors:  N E Miller; D S Thelle; O H Forde; O D Mjos
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

10.  Partially reassembled high density lipoproteins. Effects on cholesterol flux, synthesis, and esterification in normal human skin fibroblasts.

Authors:  M Picardo; J B Massey; D E Kuhn; A M Gotto; S H Gianturco; H J Pownall
Journal:  Arteriosclerosis       Date:  1986 Jul-Aug
View more
  11 in total

1.  Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.

Authors:  Urbain Tchoua; Corina Rosales; Daming Tang; Baiba K Gillard; Ashley Vaughan; Hu Yu Lin; Harry S Courtney; Henry J Pownall
Journal:  Lipids       Date:  2010-10-24       Impact factor: 1.880

2.  Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

Authors:  Baiba K Gillard; Hu-Yu Alice Lin; John B Massey; Henry J Pownall
Journal:  Biochim Biophys Acta       Date:  2009-07-25

Review 3.  Structural stability and functional remodeling of high-density lipoproteins.

Authors:  Olga Gursky
Journal:  FEBS Lett       Date:  2015-03-05       Impact factor: 4.124

Review 4.  High density lipoprotein structure-function and role in reverse cholesterol transport.

Authors:  Sissel Lund-Katz; Michael C Phillips
Journal:  Subcell Biochem       Date:  2010

5.  Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.

Authors:  Madhuri Vasudevan; Urbain Tchoua; Baiba K Gillard; Peter H Jones; Christie M Ballantyne; Henry J Pownall
Journal:  J Clin Lipidol       Date:  2013-05-25       Impact factor: 4.766

6.  HDL superphospholipidation enhances key steps in reverse cholesterol transport.

Authors:  Urbain Tchoua; Baiba K Gillard; Henry J Pownall
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

7.  Thermal transitions in human very-low-density lipoprotein: fusion, rupture, and dissociation of HDL-like particles.

Authors:  Madhumita Guha; Cheryl England; Haya Herscovitz; Olga Gursky
Journal:  Biochemistry       Date:  2007-05-01       Impact factor: 3.162

8.  Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption.

Authors:  Baiba K Gillard; Harry S Courtney; John B Massey; Henry J Pownall
Journal:  Biochemistry       Date:  2007-10-17       Impact factor: 3.162

Review 9.  HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.

Authors:  Alan T Remaley; Marcelo Amar; Dmitri Sviridov
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-10

10.  Properties of the products formed by the activity of serum opacity factor against human plasma high-density lipoproteins.

Authors:  Henry J Pownall; Harry S Courtney; Baiba K Gillard; John B Massey
Journal:  Chem Phys Lipids       Date:  2008-09-16       Impact factor: 3.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.